How long does a bufo frog ceremony last?

The active experience lasts 20–45 minutes. The recovery period — during which the person rests and is monitored — runs at minimum two to three hours. Integration, the process of making meaning from the experience, continues for weeks to months afterward and largely determines whether any lasting change results.

What is the difference between 5-MeO-DMT and DMT?

5-MeO-DMT and DMT (N,N-DMT) are chemically related tryptamines that produce fundamentally different experiences. DMT tends to produce vivid visual content and a sense of encountering entities or alternative realities. 5-MeO-DMT produces acute ego dissolution — a loss of the boundary between self and world — with little or no visual narrative. The pharmacological mechanisms differ: 5-MeO-DMT has stronger affinity for 5-HT1A receptors, which distinguishes it from classic psychedelics that act mainly on 5-HT2A.

Can you combine bufo with ayahuasca?

Not safely in close sequence. Ayahuasca contains MAOIs (monoamine oxidase inhibitors), which dramatically increase 5-MeO-DMT potency and duration. This combination has caused deaths. A minimum two to four week gap between ayahuasca and bufo ceremony is required — and any provider who does not enforce this is not operating safely.

Who should not do a bufo frog ceremony?

Absolute contraindications include: SSRIs or SNRIs (serotonin syndrome risk), MAOIs, uncontrolled cardiovascular conditions, active psychosis or unstable bipolar I, and acute psychiatric crisis. People in active suicidal crisis or severe destabilization are not appropriate candidates regardless of how much they want access. Someone on ayahuasca in the preceding two to four weeks is also not a candidate.

What does the research show about 5-MeO-DMT?

A 2019 observational study by Uthaug et al. (n=42) found significant reductions in depression and anxiety ratings maintained at four weeks after ceremonial 5-MeO-DMT use. A 2023 randomised double-blind trial by Reckweg et al. (n=36) found significant reductions in depressive symptoms at 24 hours post-administration with effects maintained at one week. The research base is smaller than psilocybin or ketamine — but placebo-controlled data supporting efficacy for treatment-resistant depression now exists.

What does integration after bufo ceremony involve?

Integration after bufo ceremony tends to be more somatic and relational than cognitive, because the experience typically has less narrative content to process. It involves making sense of an experience that is often difficult to describe, anchoring any insights into daily life, and addressing the underlying conditions — relational, environmental, psychological — that made the medicine relevant in the first place. Without this work, ceremony alone rarely produces lasting change.

What Is the Bufo Frog? The Sonoran Desert Toad and 5-MeO-DMT

Q: What is the bufo frog?

The bufo frog is Incilius alvarius — the Sonoran Desert toad. Its parotoid glands produce venom containing 5-MeO-DMT at 15–25% concentration by dry weight. When dried and vaporized, this venom produces an acute ego-dissolution experience lasting 20–45 minutes. It is used ceremonially for depression, trauma, and addiction in appropriate candidates.

Q: Is synthetic 5-MeO-DMT the same as toad venom?

The active molecule is identical. Toad venom also contains other tryptamine compounds alongside 5-MeO-DMT, whose interaction effects are not fully characterised. Whether this produces a meaningfully different experience is debated among practitioners. From a conservation standpoint, there is growing concern about the impact of ceremonial demand on wild toad populations, and synthetic 5-MeO-DMT avoids that concern entirely.

The bufo frog is Incilius alvarius — the Sonoran Desert toad. Its parotoid glands produce venom that contains 5-MeO-DMT at 15–25% concentration by dry weight. When that venom is dried and vaporized, the active experience lasts 20–45 minutes. The integration period that follows determines whether any lasting change comes from it.

Quick answer

The bufo frog (Incilius alvarius) is the Sonoran Desert toad, whose venom contains 5-MeO-DMT at 15–25% concentration. The vaporized venom produces an acute ego-dissolution experience lasting 20–45 minutes. It is used ceremonially for depression, trauma, and addiction — and is not appropriate for everyone.

Sonoran Desert landscape at dusk — the natural habitat of the bufo frog — Photo by Mo Eid via Pexels

What Is the Bufo Frog?

Incilius alvarius — formerly classified as Bufo alvarius, hence the common name — is a large toad native to the Sonoran Desert of northwestern Mexico and the southwestern United States. It inhabits desert scrub and riparian areas, emerging primarily during monsoon season.

The toad is distinguished by its parotoid glands: prominent oval structures behind the eyes that produce a milky, viscous venom as a defence against predators. That venom contains several tryptamine compounds, the most pharmacologically significant of which is 5-methoxy-N,N-dimethyltryptamine — 5-MeO-DMT — present at concentrations between 15% and 25% by dry weight.

The venom is collected by gently pressing the glands, dried on a surface, and then vaporized. The toad itself is not harmed in this process when it is done correctly. The animal is released after collection.

The name “bufo frog” is technically a misnomer — Incilius alvarius is a toad, not a frog — but it has become the common shorthand in ceremonial and clinical contexts, and referring to it that way will be understood by anyone familiar with this medicine.

Desert toad resting on dry earth — illustrating the natural habitat of Incilius alvarius — Photo by Roman Biernacki via Pexels

What Is 5-MeO-DMT and How Does It Work?

5-MeO-DMT is a naturally occurring psychedelic tryptamine found in several plant species and in the venom of Incilius alvarius. It is chemically related to DMT (N,N-DMT) but produces a fundamentally different experience — and the two are not interchangeable.

Where DMT tends to produce vivid visual content and a sense of encountering entities or alternative realities, 5-MeO-DMT produces acute ego dissolution: a temporary loss of the boundary between self and world. There is typically no visual narrative. The experience is often described as vast, oceanic, and undifferentiated. Some people report it as the most significant experience of their lives. Others find it terrifying. Most find it difficult to describe afterward.

The pharmacological mechanism is primarily agonism at the 5-HT1A and 5-HT2A serotonin receptors, with particularly strong affinity for 5-HT1A — which distinguishes it from classic psychedelics like psilocybin that act mainly on 5-HT2A. This receptor profile is thought to underlie both the distinct phenomenology of the experience and its rapid duration.

The onset is near-immediate when vaporized — seconds, not minutes. The peak lasts approximately 15–20 minutes. The full experience, including the return to ordinary consciousness, runs 20–45 minutes. Residual effects can persist for a few hours afterward.

For a direct comparison of what distinguishes 5-MeO-DMT from N,N-DMT in terms of mechanism, experience, and clinical application, the 5-MeO-DMT vs DMT breakdown covers that in detail.

Abstract light dissolving into darkness — evoking the ego-dissolution quality of 5-MeO-DMT — Photo by Kelly via Pexels

What Happens During a Bufo Ceremony

A bufo ceremony is not a long or elaborate ritual in the way an iboga ceremony is. The preparation is brief. The active experience is 20–45 minutes. The recovery period — during which the person rests, integrates, and is monitored — runs two to three hours minimum, and ideally longer.

Before the ceremony, the facilitator will have conducted medical screening to rule out contraindications — primarily cardiac conditions, current serotonergic medications, and certain psychiatric histories. This screening is not optional. Administering 5-MeO-DMT to someone on an SSRI creates a serious risk of serotonin syndrome.

The medicine is vaporized and inhaled through a pipe. The onset is rapid — most people are in the full experience within 30–60 seconds. At the peak, ordinary self-referential consciousness typically ceases. What follows varies: some people move and vocalize, some are still, most have little memory of the peak itself. The return to ordinary awareness is gradual over the following 15–20 minutes.

What differentiates a well-run ceremony from a poorly run one is not the medicine — it is the holding. The facilitator's role during the active experience is physical and energetic safety, not intervention. Afterward, the quality of presence and the structure for integration are what determine whether anything lasting comes from the experience.

The bufo ceremony page covers what happens at ExploreBwiti specifically, including cost and what to expect before, during, and after.

Quiet ceremonial space with soft natural light — the setting for a bufo ceremony — Photo by Aditya Rout via Pexels

What the Research Shows

The clinical research on 5-MeO-DMT is less extensive than that on psilocybin or ketamine, but what exists is consistent in direction.

A 2019 study published in Psychopharmacology by Uthaug et al. followed participants who received 5-MeO-DMT in group ceremonial settings. Ratings of depression and anxiety decreased significantly, with effects measurable at four weeks follow-up. Satisfaction with life increased. The sample size was modest (n=42), but the effect sizes were substantial.

A 2023 study by Reckweg et al. conducted the first randomized, double-blind, placebo-controlled trial of synthetic 5-MeO-DMT for treatment-resistant depression. The results showed significant reductions in depressive symptoms at 24 hours post-administration, with effects maintained at one week. The trial was small (n=36), but placebo-controlled data in this area is rare and the findings carry more weight than observational evidence alone.

The Multidisciplinary Association for Psychedelic Studies (MAPS) has also conducted Phase 1 safety trials for 5-MeO-DMT. The broader body of research on psychedelic-assisted therapy — including the Stanford ibogaine study — suggests that 5-MeO-DMT occupies a distinct and potentially complementary role in psychedelic medicine, particularly for trauma and depression where rapid onset of effect is clinically relevant.

The research does not yet meet the standard required for regulatory approval in most jurisdictions. What it does support is informed, medically supervised ceremonial use for appropriate candidates.

Researcher at a microscope — representing the clinical science behind 5-MeO-DMT — Photo by Jeffry S.S. via Pexels

Toad Venom or Synthetic: Does It Matter?

The active compound in bufo toad venom is 5-MeO-DMT. Synthetic 5-MeO-DMT contains the same molecule. The pharmacological mechanism is identical.

The practical differences are worth understanding. Toad venom contains other compounds alongside 5-MeO-DMT — including bufotenine and other tryptamines — whose interaction effects are not fully characterised. Whether this produces a meaningfully different experience is debated among practitioners, with some reporting qualitative differences and others reporting none.

From a conservation standpoint, there is growing concern about the impact of ceremonial demand on wild Incilius alvarius populations. The toad is not currently listed as endangered, but collection pressure in accessible areas has prompted conservationists to advocate for synthetic alternatives where possible.

5-MeO-DMT — whether from the toad or synthesized — is not a substance to approach casually. The intensity of the experience is the same regardless of source. The screening requirements are the same. The contraindications are the same.

One opinion worth stating directly: 5-MeO-DMT is not a lighter version of ibogaine. It is shorter, not easier. The intensity of ego dissolution in 20–45 minutes produces its own demands — and the absence of narrative content can make integration harder, not simpler, because there is less for the person to process intellectually afterward.

Hands holding a small glass vial — representing the distinction between natural and synthetic 5-MeO-DMT — Photo by Explore Outdoors via Pexels

Who This Is Not For

Not everyone is an appropriate candidate for bufo ceremony. The following are contraindications — not preferences, not items to discuss around:

SSRIs and SNRIs. These are absolute contraindications. The combination of 5-MeO-DMT with serotonergic medications creates a real and potentially fatal risk of serotonin syndrome. A taper is required before ceremony, and the taper timeline is not negotiable.
MAOIs. Monoamine oxidase inhibitors — including some used in combination with ayahuasca — dramatically increase 5-MeO-DMT potency and duration. The combination has caused deaths. This is not a combination to experiment with.
Cardiovascular conditions. 5-MeO-DMT produces acute cardiovascular activation — elevated heart rate, elevated blood pressure. Conditions including uncontrolled hypertension, arrhythmia, and certain structural heart conditions are contraindications. EKG and cardiovascular review are part of standard screening.
Active psychosis or bipolar I without stable management. The experience amplifies what is present. Entering it in a state of acute psychiatric instability does not produce stability.
Acute crisis. Someone in active suicidal crisis, acute grief, or severe destabilization is not an appropriate candidate at that moment — regardless of how much they want access to this medicine.
Ayahuasca in the preceding 2–4 weeks. Ayahuasca contains MAOIs. The interaction risk persists beyond the acute experience. Ceremony sequencing matters.

People sometimes arrive having done their research on dosing and mechanism but not having fully disclosed their medication history. The screening conversation exists to catch exactly this. The most common thing practitioners observe when something goes wrong in a ceremony is that something was not disclosed during intake.

Is This Right for You?

Bufo ceremony is most relevant for people working with treatment-resistant depression, trauma, or addiction who have tried other approaches and found them insufficient — and who are prepared to do the integration work that follows. It is not a first resort. It is not a gentle introduction to plant medicine.

The ceremony that didn't produce lasting change is usually the one that was followed by a return to the same environment, relationships, and unaddressed conditions that produced the problem in the first place. The experience opens a window. What is done in that window is the work.

Integration after a bufo ceremony looks different from integration after iboga — there is less narrative content to process, and the work tends to be more somatic and relational than cognitive. This is worth understanding before you arrive. The integration guide covers what that process involves in practice.

For people comparing bufo with ibogaine — either because they are considering both or trying to understand which is more appropriate for their situation — the 5-MeO-DMT vs ibogaine comparison covers mechanism, duration, use cases, and who each medicine is actually for. The application is where the conversation begins.